Prohibit conduct relating to hemp other than cannabidiol products and change provisions of the Nebraska Hemp Farming Act and the Uniform Controlled Substances Act
LB316 revises Nebraska’s Hemp Farming Act and the Uniform Controlled Substances Act to create a more detailed legal framework for hemp, cannabidiol (CBD) products, and related cannabis definitions. The bill redefines “hemp” and “cannabidiol product,” sets THC thresholds for raw and processed hemp, and clarifies that hemp includes cannabidiol products only when they meet the bill’s limits and do not contain certain chemically converted cannabinoids. It also updates numerous definitions in the controlled substances statutes to distinguish hemp and CBD products from marijuana, hashish, and other controlled substances, while preserving prohibitions on marijuana and higher-THC cannabis material.
The bill adds a 10% excise tax on retail sales of cannabidiol products beginning January 1, 2026, and requires retailers to keep electronic sales records, file monthly returns, and remit the tax to the Department of Revenue for deposit into the Property Tax Credit Cash Fund. It also establishes compliance and transport rules for hemp producers, including documentation requirements for shipments, testing records, and interstate transport conditions. In addition, it creates a consumer safe-harbor period during which individuals may surrender illegal hemp products for destruction without prosecution for possession, and it authorizes enforcement coordination by the Attorney General and law enforcement.
LB316 would significantly affect state law by narrowing and clarifying what hemp products may be cultivated, possessed, transported, sold, or consumed in Nebraska, while also creating a new tax and reporting regime for CBD products. It amends multiple sections of Nebraska statutes, including the Nebraska Hemp Farming Act and the Uniform Controlled Substances Act, and repeals prior sections that are replaced by the new definitions and regulatory structure. Retail sellers, hemp producers, processors, and law enforcement agencies are the primary affected parties, along with consumers of cannabidiol products.
The voting history suggests the bill was controversial but had enough support to advance through several stages. Multiple amendments and motions failed, indicating sustained disagreement over the bill’s scope and details, while several Kauth motions and a Judiciary amendment prevailed, showing that the bill was actively revised and ultimately moved forward. The final action of indefinite postponement indicates the bill did not become law, despite some legislative support.
The main points of contention appear to have centered on how broadly to regulate hemp-derived products, whether to impose the CBD excise tax, and how to treat products that may be chemically altered or resemble intoxicating cannabis products. Opponents or critics, reflected in the failed motions and amendments, appear to have sought to change or limit the bill’s restrictions, while supporters pushed for tighter definitions, clearer enforcement tools, and a tax structure for cannabidiol products. Overall, the bill’s tone in the legislative process appears mixed: supportive enough to advance, but with substantial resistance over cannabis policy and regulatory enforcement.
LB316 would amend Nebraska’s hemp and controlled substances laws by redefining hemp, cannabidiol products, marijuana, hashish, and related terms, and by creating new compliance, transport, and testing requirements for hemp producers. It would also impose a 10% excise tax on retail cannabidiol product sales, require retailer recordkeeping and monthly tax returns, and direct revenue to the Property Tax Credit Cash Fund. The bill would affect hemp growers, CBD retailers, processors, consumers, and law enforcement by tightening product standards and clarifying which cannabis-derived products remain lawful versus prohibited.
The legislative record shows a divided but engaged response to LB316. The bill advanced through multiple votes and amendments, suggesting meaningful support for its regulatory approach, but several proposed changes failed, indicating persistent disagreement. Overall, the sentiment appears cautiously favorable among supporters of clearer hemp regulation and CBD taxation, while opponents seemed concerned about overregulation, enforcement burdens, and the treatment of hemp-derived products.
The biggest contention points were the bill’s treatment of hemp-derived cannabinoids, especially whether certain chemically converted or intoxicating products should be excluded from lawful hemp, and whether CBD products should be taxed and regulated more like consumer goods. Some lawmakers appeared to push for broader exemptions or narrower restrictions, while others supported stronger limits, testing, and transport documentation. The failed motions and amendments suggest disputes over the bill’s balance between hemp industry accommodation, public safety, and drug-control enforcement.